Volume 21, Issue 3 (9-2021)                   ijdld 2021, 21(3): 175-185 | Back to browse issues page

XML Persian Abstract Print


1- Department of Sport Physiology, Karaj Branch, Islamic Azad University, Karaj, Iran
2- Department of Sport Physiology, Karaj Branch, Islamic Azad University, Karaj, Iran , eidyalijani@yahoo.com
Abstract:   (1366 Views)
Background: Diabetes disorders can lead to muscular burnout. The aim of this study was to determine the simultaneous effect of resistance training and endothelial stem cell injection on the factor of degeneration in the muscles of diabetic rats.
Methods: 36 male wistar rats (age 6 weeks with weight of 20±200g) were randomly divided into five groups of basic healthy, diabetic control (D), diabetic and resistance training (DR), untrained diabetic by injection of endothelial stem cells (DI), diabetic training by simultaneous injection of endothelial stem questions (DRI). Western blotting and insulin resistance index were measured by ELISA method to evaluate the changes in MURF1 expression. The data were analyzed by two-factor analysis of variance by SPSS software version 19 at a significant level of α≥%5.
Results: In this study, 6 weeks of resistance training significantly reduced MURF1 and insulin resistance index. The interactive effect of resistance training and stem cell injection also resulted in a significant decrease in murf1 levels, but insulin resistance index was not significantly superior to only training or injection.
Conclusion: Based on the findings of this study, it can be stated that resistance training or injection of endothelial ancestral cells can improve muscular degeneration, but simultaneous use of these two strategies was not superior in reducing atrophy complications in diabetic rats.
 
Full-Text [PDF 1015 kb]   (397 Downloads)    
Type of Study: Research | Subject: Special
Received: 2021/04/27 | Accepted: 2021/10/9 | Published: 2021/09/1

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.